(Q37195681)

English

KIT and mastocytosis

scientific article published on 20 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

KIT and mastocytosis (English)

1 reference

Europe PubMed Central

18 August 2017

object named as

Ken-Hong Lim

1

0 references

3

object named as

Ayalew Tefferi

1 reference

Europe PubMed Central

18 August 2017

author name string

Animesh Pardanani

2

1 reference

Europe PubMed Central

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

20 June 2008

1 reference

Europe PubMed Central

18 August 2017

Acta Haematologica

1 reference

Europe PubMed Central

18 August 2017

119

1 reference

Europe PubMed Central

18 August 2017

4

1 reference

Europe PubMed Central

18 August 2017

194-198

1 reference

Europe PubMed Central

18 August 2017

Primary structure and functional expression of rat and human stem cell factor DNAs

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Signal transduction via the stem cell factor receptor/c-Kit

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver.

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

The Kit-activating mutation D816V enhances stem cell factor--dependent chemotaxis

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Treatment of systemic mast-cell disease with cladribine

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Cladribine therapy for systemic mastocytosis.

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Imatinib for systemic mast-cell disease

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.

1 reference

https://api.crossref.org/works/10.1159%2F000140630

21 January 2018

Identifiers

10.1159/000140630

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37195681&oldid=1693773624"